[米非罗肽在神经肿瘤患者术后感染性炎症并发症联合治疗中的应用]
[The use of myelopid in the combined treatment of infectious-inflammatory complications in the postoperative period in neuro-oncology patients].
作者信息
Lisianyĭ N I, Romodanov S A, Radzievskiĭ A A, Rudenko V A, Pedachenko E G
出版信息
Zh Vopr Neirokhir Im N N Burdenko. 1991 May-Jun(3):16-8.
PMID:1661534
Abstract
Clinical observations over 48 neurosurgical patients with infectious inflammatory complications and study of their immune status showed that a course of immunocorrective therapy with myelopid produces a favourable clinical effect and normalizes the patient's immune status. Myelopid causes the best normalizing effect in patients with nontumorous pathology of the central nervous system and in extracerebral neoplasms.
摘要
对48例患有感染性炎症并发症的神经外科患者的临床观察及其免疫状态研究表明，使用米多吡明进行一个疗程的免疫纠正治疗可产生良好的临床效果，并使患者的免疫状态恢复正常。米多吡明对中枢神经系统非肿瘤性病变患者和脑外肿瘤患者具有最佳的恢复正常效果。
Zotero 插件